Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction
Abstract The objective of this study is to explore whether procalcitonin (PCT) can serve as an early biomarker of malignant cerebral edema in patients with massive cerebral infarction (MCI). Ninety-three patients with acute MCI were divided into death or survival groups based on whether they died or...
Guardado en:
Autores principales: | Yan Zhang, Gang Liu, Yuan Wang, Yingying Su, Rehana K. Leak, Guodong Cao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a318188482ab475495017ca01732f8fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
20-hydroxyeiscosatetraenoic acid may be as a predictor of malignant middle cerebral artery infarction in patients with massive middle cerebral artery infarction
por: Xingyang Yi, et al.
Publicado: (2021) -
A Nomogram Model to Predict Malignant Cerebral Edema in Ischemic Stroke Patients Treated with Endovascular Thrombectomy: An Observational Study
por: Du M, et al.
Publicado: (2020) -
Pathophysiology of Cerebral Edema—A Comprehensive Review
por: Tara Dalby, et al.
Publicado: (2021) -
Recent Technological Developments in the Diagnosis and Treatment of Cerebral Edema
por: Karthikeya P. Deshmukh, et al.
Publicado: (2021) -
Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction
por: Masaaki Kubota, et al.
Publicado: (2021)